Benutzer-Werkzeuge

Webseiten-Werkzeuge


asarum_europaeum_l

Unterschiede

Hier werden die Unterschiede zwischen zwei Versionen angezeigt.

Link zu dieser Vergleichsansicht

Beide Seiten der vorigen Revision Vorhergehende Überarbeitung
asarum_europaeum_l [2016/07/10 16:40]
andreas
asarum_europaeum_l [2017/01/02 17:57] (aktuell)
andreas
Zeile 21: Zeile 21:
 [Hagers Handbuch der Pharmazeutischen Praxis, Springer 2010]  ​ [Hagers Handbuch der Pharmazeutischen Praxis, Springer 2010]  ​
  
-In 2010, the use of all plants belonging to the Asarum species in drugs was banned in Germany by decree of the Federal Institute for Drugs and Medical Devices (BfArM). The cause of this was the detection of aristolochic acid I in homeopathic mother tinctures of Asarum europaeum with approximately ​0.044 - 0.13 ppm, and of Asarum canadense with approximately 127.4g/kg (about 0.13 ppm). \\+In 2010, the use of all plants belonging to the Asarum species in drugs was banned in Germany by decree of the Federal Institute for Drugs and Medical Devices (BfArM). The cause of this was the detection of aristolochic acid I in homeopathic mother tinctures of Asarum europaeum with 3.8-85.0 μg/kg (0.044-0.085 ppm), and of Asarum canadense with approximately 127.4µg/kg (about 0.13 ppm). \\
 [[http://​www.bfarm.de/​SharedDocs/​Downloads/​DE/​Arzneimittel/​Pharmakovigilanz/​Risikoinformationen/​RisikoBewVerf/​a-f/​aristolochia_bescheid.pdf?​__blob=publicationFile&​v=2]] [[http://​www.bfarm.de/​SharedDocs/​Downloads/​DE/​Arzneimittel/​Pharmakovigilanz/​Risikoinformationen/​RisikoBewVerf/​a-f/​aristolochia_bescheid.pdf?​__blob=publicationFile&​v=2]]
  
asarum_europaeum_l.txt · Zuletzt geändert: 2017/01/02 17:57 von andreas